Adjuvant denosumab in early breast-cancer

Lancet Oncol. 2020 Mar;21(3):e124. doi: 10.1016/S1470-2045(20)30066-8.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aromatase Inhibitors
  • Bone Density Conservation Agents*
  • Denosumab*

Substances

  • Aromatase Inhibitors
  • Bone Density Conservation Agents
  • Denosumab